AtaiBeckley (ATAI) Non Operating Income (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Non Operating Income of $1.1 million in Q1 2026.
AtaiBeckley (ATAI) Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Non Operating Income across 6 years of filings, most recently posting -$32.5 million for Q3 2025.
- Non Operating Income for Q3 2025 came in at -$32.5 million, down 1467.76% year-over-year; the trailing twelve-month figure through Sep 2025 was -$38.6 million (down 408.92% YoY), and the FY2024 annual result was -$484000.0, down 100.56% from the prior year.
- Non Operating Income was $1.1 million for Q1 2026 at AtaiBeckley.
- In the past five years, Non Operating Income ranged from a high of $70.7 million in Q3 2023 to a low of -$32.5 million in Q3 2025.
- The 5-year median for Non Operating Income is -$5000.0 (2024), against an average of $2.9 million.
- Across the five-year window, Non Operating Income jumped 70781.0% in 2023 and slumped 118680.0% in 2025, its largest moves.
- AtaiBeckley's Non Operating Income stood at -$441000.0 in 2021, then jumped by 2303.4% to $9.7 million in 2022, then jumped by 56.85% to $15.2 million in 2023, then plunged by 85.22% to $2.3 million in 2024, then tumbled by 1543.9% to -$32.5 million in 2025.
- The last three Non Operating Income figures came in at -$32.5 million (Q3 2025), -$2.4 million (Q2 2025), and -$5.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Sep 30, 2025 | -32.53 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -667,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 15.24 Mn |
| Sep 30, 2023 | 70.68 Mn |
| Jun 30, 2023 | 204,000.00 |
| Mar 31, 2023 | 243,000.00 |
| Dec 31, 2022 | 9.72 Mn |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | -441,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | -5.98 Mn |
| Mar 31, 2021 | 1.70 Mn |